STOCK TITAN

[Form 4] OSI Systems Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Paul Morben, President of the Optoelectronics Division at OSI Systems (OSIS) reported a sale on 09/04/2025 of 1,671 common shares at $236.76 per share. After the transaction he beneficially owned 8,749 shares. The Form 4 was signed on 09/05/2025. The filing identifies him as a director and officer and shows the transaction as a disposition of non-derivative common stock.

Paul Morben, presidente della divisione Optoelectronics di OSI Systems (OSIS), ha comunicato la vendita in data 04/09/2025 di 1.671 azioni ordinarie al prezzo di $236,76 ciascuna. Dopo l'operazione risultava titolare effettivo di 8.749 azioni. Il Modulo 4 è stato firmato il 05/09/2025. La segnalazione lo identifica come amministratore e dirigente e indica la transazione come una cessione di azioni ordinarie non derivate.

Paul Morben, presidente de la división de Optoelectronics en OSI Systems (OSIS), informó la venta el 04/09/2025 de 1.671 acciones ordinarias a $236.76 por acción. Tras la operación, poseía de forma beneficiaria 8.749 acciones. El Formulario 4 fue firmado el 05/09/2025. La presentación lo identifica como director y ejecutivo y refleja la transacción como una disposición de acciones ordinarias no derivadas.

Paul Morben, OSI Systems (OSIS)의 옵토일렉트로닉스 사업부장(사장)은 2025년 9월 4일에 주당 $236.761,671주의 보통주를 매도했다고 보고했습니다. 거래 후 그는 8,749주를 실질적으로 보유하고 있었습니다. Form 4는 2025년 9월 5일에 서명되었습니다. 제출 서류에는 그를 이사 겸 임원으로 기재하고 있으며, 거래를 비파생 보통주 처분으로 표시하고 있습니다.

Paul Morben, président de la division Optoelectronics chez OSI Systems (OSIS), a déclaré la vente le 04/09/2025 de 1 671 actions ordinaires au prix de 236,76 $ par action. Après la transaction, il détenait de manière bénéficiaire 8 749 actions. Le formulaire 4 a été signé le 05/09/2025. le dépôt l'identifie comme administrateur et dirigeant et présente la transaction comme une cession d'actions ordinaires non dérivées.

Paul Morben, Präsident der Optoelectronics-Division bei OSI Systems (OSIS), meldete am 04.09.2025 den Verkauf von 1.671 Stammaktien zu $236,76 je Aktie. Nach der Transaktion besaß er wirtschaftlich 8.749 Aktien. Das Formular 4 wurde am 05.09.2025 unterzeichnet. Die Einreichung führt ihn als Direktor und leitenden Angestellten und weist die Transaktion als Veräußerung nicht-derivativer Stammaktien aus.

Positive
  • Timely disclosure of the insider sale (Form 4 signed 09/05/2025)
  • Clear reporting of transaction details: shares sold, price, and post-transaction holdings
Negative
  • Insider decreased ownership by 1,671 shares, reducing beneficial holdings to 8,749 shares

Insights

Routine insider disposition; small absolute size relative to institutional holdings.

The Form 4 documents a straightforward sale of 1,671 shares by an officer/director at $236.76 on 09/04/2025, leaving 8,749 shares beneficially owned. There is no derivative activity disclosed and no amendment indicated. This appears to be a routine, single-date cash sale that provides clear, timely disclosure of insider activity.

Timely reporting consistent with Section 16 obligations; no governance red flags disclosed.

The filing shows required disclosure under Section 16 with a manual signature on 09/05/2025. The report lists the reporting person's role and the transaction code for a disposition. There is no indication of related-party transactions, 10b5-1 plan notation, or amendments, therefore the disclosure meets routine governance expectations.

Paul Morben, presidente della divisione Optoelectronics di OSI Systems (OSIS), ha comunicato la vendita in data 04/09/2025 di 1.671 azioni ordinarie al prezzo di $236,76 ciascuna. Dopo l'operazione risultava titolare effettivo di 8.749 azioni. Il Modulo 4 è stato firmato il 05/09/2025. La segnalazione lo identifica come amministratore e dirigente e indica la transazione come una cessione di azioni ordinarie non derivate.

Paul Morben, presidente de la división de Optoelectronics en OSI Systems (OSIS), informó la venta el 04/09/2025 de 1.671 acciones ordinarias a $236.76 por acción. Tras la operación, poseía de forma beneficiaria 8.749 acciones. El Formulario 4 fue firmado el 05/09/2025. La presentación lo identifica como director y ejecutivo y refleja la transacción como una disposición de acciones ordinarias no derivadas.

Paul Morben, OSI Systems (OSIS)의 옵토일렉트로닉스 사업부장(사장)은 2025년 9월 4일에 주당 $236.761,671주의 보통주를 매도했다고 보고했습니다. 거래 후 그는 8,749주를 실질적으로 보유하고 있었습니다. Form 4는 2025년 9월 5일에 서명되었습니다. 제출 서류에는 그를 이사 겸 임원으로 기재하고 있으며, 거래를 비파생 보통주 처분으로 표시하고 있습니다.

Paul Morben, président de la division Optoelectronics chez OSI Systems (OSIS), a déclaré la vente le 04/09/2025 de 1 671 actions ordinaires au prix de 236,76 $ par action. Après la transaction, il détenait de manière bénéficiaire 8 749 actions. Le formulaire 4 a été signé le 05/09/2025. le dépôt l'identifie comme administrateur et dirigeant et présente la transaction comme une cession d'actions ordinaires non dérivées.

Paul Morben, Präsident der Optoelectronics-Division bei OSI Systems (OSIS), meldete am 04.09.2025 den Verkauf von 1.671 Stammaktien zu $236,76 je Aktie. Nach der Transaktion besaß er wirtschaftlich 8.749 Aktien. Das Formular 4 wurde am 05.09.2025 unterzeichnet. Die Einreichung führt ihn als Direktor und leitenden Angestellten und weist die Transaktion als Veräußerung nicht-derivativer Stammaktien aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Morben Paul Keith

(Last) (First) (Middle)
12525 CHADRON AVE.

(Street)
HAWTHORNE CA 90250

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OSI SYSTEMS INC [ OSIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRES., OPTOELECTRONICS DIV
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/04/2025 S 1,671 D $236.76 8,749 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Paul Morben 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did OSIS report on 09/04/2025?

Paul Morben sold 1,671 shares of OSI Systems common stock at $236.76 per share on 09/04/2025.

How many OSIS shares does the reporting person own after the sale?

After the reported disposition the reporting person beneficially owned 8,749 shares.

What is Paul Morben's role at OSI Systems as listed on the Form 4?

He is listed as a Director and Officer with the title President, Optoelectronics Division.

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 09/05/2025.

Was any derivative or option activity reported in this filing?

No. The filing shows only a non-derivative common stock disposition and contains no derivative securities entries.
Osi Systems

NASDAQ:OSIS

OSIS Rankings

OSIS Latest News

OSIS Latest SEC Filings

OSIS Stock Data

3.97B
15.88M
4.61%
116.78%
12.45%
Electronic Components
Semiconductors & Related Devices
Link
United States
HAWTHORNE